Taysha Gene Therapies Inc TSHA:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/12/22 EDT
4.10quote price arrow up+0.15 (+3.80%)
Volume
159,169
52 week range
2.33 - 21.90
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.10
  • 52 Week High21.90
  • 52 Week High Date09/07/21
  • 52 Week Low2.33
  • 52 Week Low Date05/25/22

Key Stats

  • Market Cap166.25M
  • Shares Out40.55M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-64.81

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.10
  • 52 Week High21.90
  • 52 Week High Date09/07/21
  • 52 Week Low2.33
  • 52 Week Low Date05/25/22
  • Market Cap166.25M
  • Shares Out40.55M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-64.81

RATIOS/PROFITABILITY

  • EPS (TTM)-4.83
  • P/E (TTM)-0.85
  • Fwd P/E (NTM)-1.16
  • EBITDA (TTM)-181.683M
  • ROE (TTM)-169.30%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)114.89%

EVENTS

  • Earnings Date11/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Taysha Gene Therapies Inc

There is no recent news for this security.

Profile

MORE
Taysha Gene Therapies, Inc. is a patient-centric gene therapy company. The Company is focused on developing and commercializing adeno-associated virus (AAV)-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS). Its portfolio of gene therapy candidates targets a range of neurological indications across three distinct therapeutic categories: neurodegenerative diseases, neurodevelopmental disorders and genetic epilepsies. Its product...
Sean Nolan
Independent Chairman of the Board
Ra Session II
President, Chief Executive Officer, Director
Kamran Alam
Chief Financial Officer
Address
3000 Pegasus Park Drive, Suite 1430
Dallas, TX
75247
United States

Top Peers

SYMBOLLASTCHG%CHG
VIRX
Viracta Therapeutics Inc
4.18+0.15+3.72%
CELC
Celcuity Inc
10.40-0.24-2.26%
IMUX
Immunic Inc
5.25+0.33+6.71%
PDSB
PDS Biotechnology Corp
5.41+0.12+2.27%
IMRX
Immuneering Corp
5.94-0.39-6.16%